Problem#3Mimicking nature by codelivery of stimulant and inhibitor

Containing vegf v ava bvb all resulted in enhanced

Info iconThis preview shows page 1. Sign up to view the full content.

View Full Document Right Arrow Icon
This is the end of the preview. Sign up to access the rest of the document.

Unformatted text preview: ed in enhanced perfusion in the ischemic limb compared to the implantation of blank scaffolds (B). PNAS ∣ October 19, 2010 ∣ vol. 107 ∣ no. 42 ∣ 17937 terns, and avian feather size and spacing (35–37). The polymer system described in the present paper is also robust against fluctuations in angiogenic VEGF threshold and initial encapsulated mass. Similarly, natural processes employ mechanisms to enhance the robustness of morphogen gradients against fluctuations in gene dosage or environmental conditions (38). These mechanisms include self-enhanced degradation (39), complexes with restricted diffusion (40), feedback (41), or their combination. In the polymeric system described, since VEGF and anti-VEGF have a canceling effect, increased doses in both of these proteins will likely not affect the width of the APR. In order to alter the width of the APR, VEGF and anti-VEGF doses are expected to be inversely adjusted. Many researchers have proposed the delivery of multiple agents with different release methodologies in order to address complex biological events (1, 42, 43). This study achieves spatial restriction and temporal stability of an active concentration profile of a drug by simultaneously delivering a direct inhibitor. containing layers were comparable to previous studies with protracted release of VEGF (18, 20). Despite the reduction in total active VEGF delivered in the AVA scaffolds, the resulting vessel densities and perfusion in the scaffold and in the underlying muscles were not statistically different from those of the scaffolds delivering VEGF only. The AVA scaffolds also showed moderate improvement in preventing necrosis compared to VEGF only and BVB. The free-VEGF concentration in the V and BVB scaffolds likely was an oversaturating dose, or the excessive VEGF created nonproductive vasculature in these conditions (9, 10, 34). Another possibility is that the lowered microenvironmental VEGF concentration in the AVA condition resulted in more structurally effective blood vessels in the central layer that compensated for the reduced blood vessel densities in the two side layers. Aside from a reduction in the concentration of the free activator, VEGF, the initial spatial separation of the inhibitor and activator lead to a spatially sharp and restricted angiogenic region. This methodology mimics developmental processes in nature that use opposing factors as a method of control. Reaction-diffusion mechanisms involving an inhibitor and an activator manifest in murine interfollicular patterns, angelfish skin pat- ACKNOWLEDGMENTS. Financial support was provided by Wyss Institute and by National Institutes of Health R01 HL069957. We also thank Biological Resources of the National Cancer Institute for providing VEGF for our studies. 1. Richardson TP, et al. (2001) Polymeric system for dual growth factor delivery. Nat Biotechnol 19:1029–1034. 2. Bonauer A, et al. (2009) MicroRNA-92a controls angiogenesis and functional recovery of ischemic...
View Full Document

Ask a homework question - tutors are online